Found 391 matching trials
A Combination Study of CAR-T Therapy in r/r B-NHL
PHASE2In registry studies of CAR-T products that have been marketed globally, pat...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
PHASE1This phase I trial studies the side effects and best dose of selinexor when...
Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
PHASE1This phase Ib/II trial studies the side effects and best dose of toll-like ...
Location
Stanford University, School of Medicine
Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
PHASE2The primary objective of the study is to evaluate efficacy of entospletinib...
Location
University of Alabama at Birmingham
Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib
PHASE2The goal of this clinical trial was to evaluate whether zanubrutinib can ef...
Location
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital
Combination of Ibrutinib and As2O3 in the Treatment of CLL
PHASE3The purpose of this study is to determine whether the combination of As2O3 ...
Location
Multiple Locations
Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance
PHASE2This phase II trial studies how well the combination of ibrutinib and venet...
Location
Multiple Locations
A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms
PHASE1The purpose of this study is to evaluate the safety and tolerability of Bru...
Location
Multiple Locations
Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma
PHASE2This pilot phase II trial studies ibrutinib in treating patients with trans...
Location
Fred Hutch/University of Washington Cancer Consortium
Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
PHASE1The purpose of this study is to test the safety of combined use of the stud...
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)